Editas Medicine director Ellinor Patrick Thomas II files initial beneficial ownership statement
E
EDIT• Form 3 filing for new director reporting owner
- Editas Medicine filed a Form 3 showing director Ellinor Patrick Thomas II as a reporting owner, dated Aug. 6.
Related News
I
Immix Biopharma Q2 FY26 net loss widens to USD 11.56 million; G&A expense more than doubled to USD 7.12 million
IMMX•
